SCHEMBL8555926

SCHEMBL8555926

OC(c1ccccn1)c1cc(-c2ccccc2)nc2c(C(F)(F)F)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 1/20 0.41
ESR1 P03372 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
MAPT P10636 1/20 0.40
KCNH2 Q12809 8/20 0.38
ADORA2A P29274 6/20 0.38
ADORA1 P30542 6/20 0.38
CYP3A4 P08684 4/20 0.38
ADORA3 P0DMS8 2/20 0.38
ADORA2B P29275 1/20 0.38
CYP2C19 P33261 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NR1I2 O75469 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
HTR1A P08908 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10311379 0.91 MAPT (0.39) TACR3ESR1TRPV1MAPTKCNH2
SCHEMBL10311377 0.88 GRM5 (0.39) MAPTADORA2AADORA1ADORA2BSCN9A
SCHEMBL7288128 0.85 KCNH2 (0.52) ESR1MAPTKCNH2ADORA2AADORA1
SCHEMBL8941191 0.85 KCNH2 (0.52) ESR1MAPTKCNH2ADORA2AADORA1
SCHEMBL7278581 0.85 KCNH2 (0.52) ESR1MAPTKCNH2ADORA2AADORA1
SCHEMBL8554883 0.80 KCNH2 (0.36) MAPTKCNH2ADORA2AADORA1CYP3A4
SCHEMBL16307497 0.74 KDM4E (0.49) TACR3MAPTCYP3A4KDM4ETP53
SCHEMBL10674396 0.74 ESR1 (0.51) ESR1TRPV1ADORA2AADORA1ADORA3
SCHEMBL7212295 0.72 ADORA2A (0.69) TACR3MAPTADORA2AADORA1CYP1A2
SCHEMBL15212407 0.72 ACP1 (0.56) TACR3MAPTCYP2C19KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716265-B2 4-quinolinemethanols as anti-malarial agents JENRIN DISCOVERY, INC. (US) 2014-05-06 US disclosed
US-20120178717-A1 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS JENRIN DISCOVERY (US) 2012-07-12 US disclosed
US-20120178717-A1 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS JENRIN DISCOVERY (US) 2012-07-12 US disclosed
WO-2012068560-A2 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS JENRIN DISCOVERY (US) 2012-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178717-A1 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS CYP51A1, SQLE, NQO2 TACR3 2943/4885ESR1 4474/4885TRPV1 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.